T. Miyazaki et al. / Tetrahedron 67 (2011) 1598e1602
1601
dissolved in 15 mL of anhydrous DMF were added dropwise to the
above DMF solution at ꢀ5 to 0 ꢁC over 20 min. The reaction mixture
was stirred at room temperature for 12 h. After the reaction, the
mixture was poured into satd NaHCO3 solution. Organic materials
were extracted with three 150-mL portions of ethyl ether. The
combined ethereal solution was concentrated under reduced
pressure to give the residual oil, which was then treated with 5%
sulfuric acid in 50% aqueous methanol at room temperature for 3 h.
In the case of the reaction of 14aef, each of the reaction mixture
was found to consist of a complex mixture of several components.
Then, the mixture was further treated with 10% aqueous sulfuric
acid for another 3 h. The organic components were then extracted
with ethyl ether three times, and the combined ethereal solution
was dried over anhydrous MgSO4. After removal of MgSO4 by fil-
tration and evaporation of the solvent, isolation by column chro-
matography gave the corresponding cyclization products in
satisfactory yield.
cmꢀ1): 3425 (OH), 3046 (AreH), 2947 (CeH), 1734 (C]O), 1229
(CeOeC), 734. MS (EI): m/z 236 (Mþ). Mp: 99.8102.6 ꢁC. Anal. Calcd
for C13H16O4: C, 66.09; H, 6.83, found: C, 66.12; H, 6.86.
3.2.6. Methyl-3-(1-oxo-2-indanyl) butanoate (7b). Diastereomers
ratio¼6:4. Mixture of isomers. 1H NMR (400 MHz, CDCl3, ppm):
d
0.86 (d, J¼6.8 Hz, 1.8H), 1.00 (d, J¼7.1 Hz, 1.2H), 2.29e2.95 (m, 5H),
3.20 (dd, J¼7.6 , 17.6 Hz, 0.6H), 3.29 (dd, J¼8.1 , 17.3 Hz, 0.4H), 3.64
(s, 1.2H), 3.69 (s, 1.8H), 7.34e7.38 (m, 1H), 7.46e7.48 (m, 1H),
7.56e7.60 (m, 1H), 7.71e7.75 (m, 1H). IR (neat, cmꢀ1): 3077 (AreH),
2953 (CeH), 1735 (ester), 1709 (C]O). MS (EI): m/z 232 (Mþ). Anal.
Calcd for C14H16O3: C, 72.39; H, 6.94, found: C, 72.36; H, 7.07.
3.2.7. Methyl-3-(1-oxo-2-indanyl)-2-methylpropanoate
(7c).
Diastereomers ratio¼1:1. Mixture of isomers. 1H NMR (400 MHz,
CDCl3, ppm):
d
1.25 (d, J¼7.1 Hz, 1.5H), 1.26 (d, J¼7.1 Hz, 1.5H),
1.56e3.70 (m, 5H,), 3.33 (dd, J¼7.8 , 17.1 Hz, 0.5H), 3.39 (dd, J¼7.8 ,
16.8 Hz, 0.5H), 3.39 (d, J=3.4 Hz, 1.5H), 3.70 (d, J¼3.4 Hz, 1.5H),
7.34e7.38 (m, 1H), 7.43e7.46 (m, 1H), 7.57e7.60 (m, 1H), 7.73e7.75
(m, 1H). IR (neat, cmꢀ1): 3033 (AreH), 2950 (CeH), 1731 (ester).
1711 (C]O). MS (EI): m/z 232 (Mþ). Anal. Calcd for C14H16O3: C,
72.39; H, 6.94, found: C, 72.43; H, 7.16.
In the fivefolded scale reaction of 2a under the similar reaction
conditions, the product 5a was isolated in a 70% yield.
All the cyclization products, 5aeg, 8aec, 10, 15aef, and 6,
obtained in this study were characterized by spectroscopic and
elemental analyses or comparison of spectroscopic and chro-
matographic behaviors with those of authentic samples.
3.2.8. (3aS
drocyclopent[a]inden-3-one (8b). endo:exo¼56:44. Mixture of iso-
mers. 1H NMR (400 MHz, CDCl3, ppm):
*
,8aS )-3a-Hydroxy-1-methyl-1,2,3,3a,8,8a-hexahy-
*
3.2. Analytical data for new compounds among the products
d
1.02 (d, J¼6.7 Hz, 1.68H),
3.2.1. 2-Hydroxy-2-(3-methoxyphenyl)cyclopentanone (5b). 1H NMR
1.13 (d, J¼6.8 Hz, 1.32H), 1.85e3.64 (m, 5H), 3.30 (br s, 1H),
7.21e7.41 (m, 4H). IR (KBr, cmꢀ1): 3443 (OH), 3064 (AreH), 2960
(CeH),1732 (C]O). MS (EI): m/z 202 (Mþ). Anal. Calcd for C13H14O2:
C, 77.20; H, 6.98, found: C, 77.16; H, 6.94.
(400 MHz, CDCl3, ppm):
d 1.81e1.89 (m, 1H), 2.03e2.09 (m, 1H),
2.18e2.25 (m, 1H), 2.44e2.52 (m, 3H), 2.99 (br s, 1H), 3.80 (s, 3H),
6.83e6.94 (m, 3H), 7.25e7.30 (m, 1H). 13C NMR (100 MHz, CDCl3,
ppm): d 17.27, 35.75, 37.82, 55.27, 80.56,111.62,113.43,117.84,129.59,
142.19,159.66, 218.27. IR (neat, cmꢀ1): 3441 (OH), 3066 (AreH), 2965
(CeH), 1742 (C]O), 1265 (CeOeC). MS (EI): m/z 206 (Mþ). Anal.
Calcd for C12H14O3: C, 69.88; H, 6.84, found: C, 69.85; H, 6.77.
3.2.9. (3aS
drocyclopent[a]inden-3-one (8c). endo:exo¼65:35. Mixture of iso-
mers. 1H NMR (400 MHz, CDCl3, ppm):
*
,8aR
*
)-3a-Hydroxy-2-methyl-1,2,3,3a,8,8a-hexahy-
d
1.14 (d, J¼6.8 Hz, 1.05H),
1.22 (d, J¼6.8 Hz, 1.95H), 1.59e3.45 (m, 5H), 3.09 (br s, 0.65H), 3.28
(br s, 0.35H), 7.21e7.41 (m, 4H). IR (neat, cmꢀ1): 3437 (OH), 3065
(AreH), 2931 (CeH),1740 (C]O). MS (EI): m/z 202 (Mþ). Anal. Calcd
for C13H14O2: C, 77.20; H, 6.98, found: C, 77.43; H, 7.08.
3.2.2. 2-Hydroxy-2-(4-chlorophenyl)cyclopentanone (5c). 1H NMR
(400 MHz, CDCl3, ppm):
d 1.80e1.89 (m, 1H), 2.04e2.13 (m, 1H),
2.19e2.27 (m, 1H), 2.39e2.54 (m, 3H), 2.98 (br s, 1H), 7.26e7.35 (m,
4H). 13C NMR (100 MHz, CDCl3, ppm):
d 17.31, 35.75, 37.92, 80.09,
127.17, 128.73, 134.04, 139.13, 217.93. IR (neat, cmꢀ1): 3438 (OH),
3049 (AreH), 2974 (CeH), 1745 (C]O). MS (EI): m/z 210 (Mþ). Anal.
Calcd for C11H11ClO2: C, 62.72; H, 5.26, found: C, 62.78; H, 5.45.
3.2.10. Diethyl-2-[3-(3-methoxyphenyl)-1-phenyl-3-oxopropyl]-mal-
onate (14f). 1H NMR (400 MHz, CDCl3, ppm):
d
1.00 (t, J¼7.3 Hz, 3H),
1.24 (t, J¼7.3 Hz, 3H), 3.44 (dd, J¼7.3 , 16.5 Hz, 1H), 3.57 (dd, J¼4.3 ,
16.5 Hz,1H), 3.81 (d, J¼9.9 Hz,1H), 3.82 (s, 3H), 3.95(q, J¼7.3 Hz, 2H),
4.14e4.23 (m, 3H), 7.07e7.51 (m, 9H). 13C NMR (100 MHz, CDCl3,
3.2.3. 2-Hydroxy-2-(3-chlorophenyl)cyclopentanone (5d). 1H NMR
(270 MHz, CDCl3, ppm):
d
1.81e1.92 (m, 1H), 2.04e2.14 (m, 1H),
ppm): d 13.73, 14.00, 40.87, 42.75, 55.40, 57.56, 61.32, 61.64, 112.17,
2.20e2.28 (m,1H), 2.39e2.55(m, 3H), 3.03(brs,1H),7.17e7.36 (m, 4H).
119.86, 120.74, 127.12, 128.23, 128.37, 129.50, 140.39, 159.75, 167.71,
168.32, 197.35. IR (neat, cmꢀ1): 3020 (AreH), 2992 (CeH), 1725 (C]
O),1676 (C]O) 1240 (CeOeC). MS (EI): m/z 398 (Mþ). Anal. Calcd for
C23H26O6: C, 69.33; H, 6.58, found: C, 69.30; H, 6.51.
13C NMR (67.5 MHz, CDCl3, ppm):
d 17.38, 35.75, 35.88, 80.14, 123.78,
126.04, 128.22, 129.80, 134.51, 142.83, 217.69. IR (neat, cmꢀ1): 3435
(OH), 3052 (AreH), 2972 (CeH), 1743 (C]O). MS (EI): m/z 210 (Mþ).
Anal. Calcd for C11H11ClO2: C, 62.72; H, 5.26, found: C, 62.82; H, 5.12.
3.2.11. 2-(4-Methoxyphenyl)-4-phenyl-2-cyclopenten-1-one (15b).
3.2.4. 2-Hydroxy-2-(4-methylphenyl)cyclopentanone (5e). 1H NMR
1H NMR (400 MHz, CDCl3, ppm):
d
2.54 (dd, J¼1.8 ,18.6 Hz,1H), 3.10
(270 MHz, CDCl3, ppm):
d
1.71e1.88 (m, 1H), 1.96e2.10 (m, 1H),
(dd, J¼6.8 , 18.6 Hz, 1H), 3.82 (s, 3H), 4.11e4.14 (m, 1H), 6.92e6.94
2.13e2.45 (m, 1H), 2.14 (s, 3H), 2.39e2.53 (m, 3H), 3.15 (br s, 1H),
(m, 2H), 7.18e7.35 (m, 5H), 7.68e7.76 (m, 3H) ppm. 13C NMR
7.12 (d, J¼8.5 Hz, 2H) 7.24 (d, J¼8.5 Hz, 2H). 13C NMR (67.5 MHz,
(100 MHz, CDCl3):
d 43.58, 45.65, 55.22, 113.86, 123.66, 127.11,
CDCl3, ppm):
d
17.17, 21.10, 35.56, 37.57, 80.41, 125.59, 129.18, 137.35,
127.20, 128.37, 128.94, 129.09, 142.05, 142.12, 158.67, 207.43. IR
(neat, cmꢀ1): 3020 (AreH), 2982 (CH), 1733 (C]O), 1246 (CeOeC)
cmꢀ1. MS (EI): m/z 264 (Mþ). Anal. Calcd for C18H16O2: C, 86.79; H,
6.10, found: C, 86.80; H, 6.12.
137.82, 218.45. IR (neat, cmꢀ1): 3435 (OH), 3054 (AreH), 2978
(CeH), 1744 (C]O). MS (EI): m/z 190 (Mþ). Anal. Calcd for C12H14O2:
C, 75.76; H, 7.42, found: C, 75.86; H, 7.12.
3.2.5. 2-Hydroxy-2-(2,5-dimethoxyphenyl)cyclopentanone (5f). 1H
3.2.12. 2-(4-Chlorophenyl)-4-phenyl-2-cyclopenten-1-one (15c). 1H
NMR (400 MHz, CDCl3, ppm):
d
2.03e2.14 (m, 3H), 2.31e2.34 (m,
NMR (400 MHz, CDCl3, ppm):
(dd, J¼4.0 , 16.0 Hz, 1H), 4.15e4,18 (m, 1H), 7.19e7.38 (m, 7H),
7.71e7.85 (m, 3H). 13C NMR (100 MHz, CDCl3, ppm):
43.73, 45.52,
d
2.57 (dd, J¼4.0 , 16.0 Hz, 1H), 3.12
1H), 2.45 (br s, 1H), 2.48e2.50 (m, 1H), 2.55e2.62 (m, 1H), 3.69 (s,
3H), 3.79 (s, 3H), 6.72e6.85 (m, 2H) 7.10e7.21 (m, 1H). 13C NMR
d
(100 MHz, CDCl3, ppm):
112.44, 112.63, 113.33, 132.62, 148.98, 154.01, 217.92. IR (neat,
d
19.69, 36.49, 37.81, 55.70, 55.78, 78.42,
127.23, 127.27, 128.50, 128.69, 129.02, 131.13, 141.90, 142.86, 153.01,
160.51, 207.09. IR (neat, cmꢀ1): 3029 (AreH), 2990 (CeH), 1706 (C]